BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7757 related articles for article (PubMed ID: 19650178)

  • 1. Antitumor activity of Ru(III) complexes carrying beta-diketonato ligands in vitro and in vivo.
    Arandjelovic SS; Bjelogrlic KS; Malesevic NN; Tesic LjZ; Radulovic SS
    J BUON; 2009; 14(2):271-9. PubMed ID: 19650178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, characterization, and detailed electrochemistry of binuclear ruthenium(III) complexes bridged by bisacetylacetonate. Crystal and molecular structures of [[Ru(acac)2]2(tae)] (acac = 2,4-pentanedionate ion, tae = 1,1,2,2-tetraacetylethanate dianion).
    Koiwa T; Masuda Y; Shono J; Kawamoto Y; Hoshino Y; Hashimoto T; Natarajan K; Shimizu K
    Inorg Chem; 2004 Oct; 43(20):6215-23. PubMed ID: 15446866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of In vitro cytotoxicity, associated to increased G(2)-M cell fraction and inhibition of matrigel invasion, may predict In vivo-selective antimetastasis activity of ruthenium complexes.
    Zorzet S; Bergamo A; Cocchietto M; Sorc A; Gava B; Alessio E; Iengo E; Sava G
    J Pharmacol Exp Ther; 2000 Dec; 295(3):927-33. PubMed ID: 11082425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 6(5H)-phenanthridinone, an inhibitor of poly(ADP-ribose) polymerase, on cultured tumor cells.
    Weltin D; Marchal J; Dufour P; Potworowski E; Oth D; Bischoff P
    Oncol Res; 1994; 6(9):399-403. PubMed ID: 7703525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and chemical-pharmacological characterization of the antimetastatic NAMI-A-type Ru(III) complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine).
    Velders AH; Bergamo A; Alessio E; Zangrando E; Haasnoot JG; Casarsa C; Cocchietto M; Zorzet S; Sava G
    J Med Chem; 2004 Feb; 47(5):1110-21. PubMed ID: 14971891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro combined effect of a new series of copper (II) complexes with cisplatin or epirubicin on human breast and cervical cancer cell lines.
    Geromichalos GD; Katsoulos GA; Hadjikostas CC; Kortsaris AH; Kyriakidis DA
    Drugs Exp Clin Res; 1998; 24(2):93-104. PubMed ID: 9675550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiproliferative action of isatine-beta-thiocarbohydrazone and N-ethylisatine-beta-thiocarbohydrazone on human PBMC and on two neoplastic cell lines.
    Juranić Z; Anastasova F; Juranić I; Stanojković T; Radulović S; Vuletić N
    J Exp Clin Cancer Res; 1999 Sep; 18(3):317-24. PubMed ID: 10606176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the antiproliferative activity of anticancer drugs in hematopoietic tumor cell lines by the poly(ADP-ribose) polymerase inhibitor 6(5H)-phenanthridinone.
    Holl V; Coelho D; Weltin D; Hyun JW; Dufour P; Bischoff P
    Anticancer Res; 2000; 20(5A):3233-41. PubMed ID: 11062748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of in vivo lung metastases by dinuclear ruthenium complexes is coupled to inhibition of in vitro tumour invasion.
    Bergamo A; Stocco G; Casarsa C; Cocchietto M; Alessio E; Serli B; Zorzet S; Sava G
    Int J Oncol; 2004 Feb; 24(2):373-9. PubMed ID: 14719114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of tamoxifen sensitivity control the nature of the synergistic interaction between tamoxifen and cisplatin.
    McClay EF; Jones JA; Winski PJ; Albright KD; Christen RD; Howell SB
    Cancer Res; 1996 Sep; 56(17):3993-7. PubMed ID: 8752169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro schedule-dependent interaction between paclitaxel and oxaliplatin in human cancer cell lines.
    Tanaka R; Ariyama H; Qin B; Takii Y; Baba E; Mitsugi K; Harada M; Nakano S
    Cancer Chemother Pharmacol; 2005 Jun; 55(6):595-601. PubMed ID: 15731917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effects of geldanamycin and antitumor drugs.
    Liao ZY; Zhang SH; Zhen YS
    Yao Xue Xue Bao; 2001 Aug; 36(8):569-75. PubMed ID: 12579931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor properties of some 2-[(dimethylamino)methyl]phenylgold(III) complexes.
    Buckley RG; Elsome AM; Fricker SP; Henderson GR; Theobald BR; Parish RV; Howe BP; Kelland LR
    J Med Chem; 1996 Dec; 39(26):5208-14. PubMed ID: 8978849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compared cytotoxicity effects of five anticancer drugs on human (HBL) and mouse (B16) melanoma cells in vitro.
    Arnould R; Dubois J; Abikhalil F; Libert A; Ghanem G; Atassi G; Hanocq M; Lejeune FJ
    Anticancer Res; 1990; 10(3):789-93. PubMed ID: 2369092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Ru(III), Rh(III), Pd(II) and Pt(II) complexes with ligands incorporating azole and pyrimidine rings. I. Antiproliferative activity in vitro.
    Wiśniewski MZ; Wietrzyk J; Opolski A
    Arch Immunol Ther Exp (Warsz); 2000; 48(1):51-5. PubMed ID: 10722233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct effects of dinuclear ruthenium(III) complexes on cell proliferation and on cell cycle regulation in human and murine tumor cell lines.
    Bergamo A; Stocco G; Gava B; Cocchietto M; Alessio E; Serli B; Iengo E; Sava G
    J Pharmacol Exp Ther; 2003 May; 305(2):725-32. PubMed ID: 12606643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of in vitro cytotoxicity with preclinical in vivo antitumor activity.
    Rose WC; Schurig JE; Meeker JB
    Anticancer Res; 1988; 8(3):355-67. PubMed ID: 3389740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of platinum drugs against melanoma cell lines: is it modulated in vitro in the presence of tamoxifen?
    Mohammed MQ; Photiou A; Shah P; Retsas S
    Anticancer Res; 1995; 15(4):1319-26. PubMed ID: 7654015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor apoptosis induced by ruthenium(II)-ketoconazole is enhanced in nonsusceptible carcinoma by monoclonal antibody to EGF receptor.
    Strasberg Rieber M; Anzellotti A; Sánchez-Delgado RA; Rieber M
    Int J Cancer; 2004 Nov; 112(3):376-84. PubMed ID: 15382061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity.
    Ronconi L; Giovagnini L; Marzano C; Bettìo F; Graziani R; Pilloni G; Fregona D
    Inorg Chem; 2005 Mar; 44(6):1867-81. PubMed ID: 15762713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 388.